These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18334756)

  • 1. Increased levels of magnetic iron compounds in Alzheimer's disease.
    Pankhurst Q; Hautot D; Khan N; Dobson J
    J Alzheimers Dis; 2008 Feb; 13(1):49-52. PubMed ID: 18334756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects.
    Bulk M; van der Weerd L; Breimer W; Lebedev N; Webb A; Goeman JJ; Ward RJ; Huber M; Oosterkamp TH; Bossoni L
    Sci Rep; 2018 May; 8(1):6898. PubMed ID: 29720594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue.
    Hautot D; Pankhurst QA; Khan N; Dobson J
    Proc Biol Sci; 2003 Aug; 270 Suppl 1(Suppl 1):S62-4. PubMed ID: 12952638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.
    Delgado-González JC; Florensa-Vila J; Mansilla-Legorburo F; Insausti R; Artacho-Pérula E
    J Alzheimers Dis; 2017; 57(2):461-473. PubMed ID: 28269774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue.
    Collingwood JF; Mikhaylova A; Davidson M; Batich C; Streit WJ; Terry J; Dobson J
    J Alzheimers Dis; 2005 Aug; 7(4):267-72. PubMed ID: 16131727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional MRI in the early diagnosis of Alzheimer's disease: is it time to refocus?
    Prince SE; Woo S; Doraiswamy PM; Petrella JR
    Expert Rev Neurother; 2008 Feb; 8(2):169-75. PubMed ID: 18271703
    [No Abstract]   [Full Text] [Related]  

  • 9. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Hänggi J; Streffer J; Jäncke L; Hock C
    J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging.
    Raven EP; Lu PH; Tishler TA; Heydari P; Bartzokis G
    J Alzheimers Dis; 2013; 37(1):127-36. PubMed ID: 23792695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.
    Jack CR; Petersen RC; Xu YC; Waring SC; O'Brien PC; Tangalos EG; Smith GE; Ivnik RJ; Kokmen E
    Neurology; 1997 Sep; 49(3):786-94. PubMed ID: 9305341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.
    Bartzokis G; Sultzer D; Mintz J; Holt LE; Marx P; Phelan CK; Marder SR
    Biol Psychiatry; 1994 Apr; 35(7):480-7. PubMed ID: 8018799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
    Everett J; Collingwood JF; Tjendana-Tjhin V; Brooks J; Lermyte F; Plascencia-Villa G; Hands-Portman I; Dobson J; Perry G; Telling ND
    Nanoscale; 2018 Jul; 10(25):11782-11796. PubMed ID: 29688240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of neuronal lipofuscin in the superior temporal gyrus in Alzheimer's disease do not differ from non-diseased controls: a comparison with disease-related changes in the superior frontal gyrus.
    Mountjoy CQ; Dowson JH; Harrington C; Cairns MR; Wilton-Cox H
    Acta Neuropathol; 2005 May; 109(5):490-6. PubMed ID: 15759127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.
    Deibel MA; Ehmann WD; Markesbery WR
    J Neurol Sci; 1996 Nov; 143(1-2):137-42. PubMed ID: 8981312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7T MRI allows detection of disturbed cortical lamination of the medial temporal lobe in patients with Alzheimer's disease.
    Kenkhuis B; Jonkman LE; Bulk M; Buijs M; Boon BDC; Bouwman FH; Geurts JJG; van de Berg WDJ; van der Weerd L
    Neuroimage Clin; 2019; 21():101665. PubMed ID: 30642758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the structural form of iron in ferritin cores associated with progressive supranuclear palsy and Alzheimer's disease.
    Dobson J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL49-50. PubMed ID: 11936873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.
    Jagust WJ; Eberling JL; Richardson BC; Reed BR; Baker MG; Nordahl TE; Budinger TF
    Brain Res; 1993 Dec; 629(2):189-98. PubMed ID: 8111623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of T2 signal intensities in Alzheimer's disease.
    Parsey RV; Krishnan KR
    Psychiatry Res; 1998 Jun; 82(3):181-5. PubMed ID: 9754442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
    Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
    ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.